CME References

Angier E, Willington J, Scadding G, Holmes S, Walker S. Management of allergic rhinitis: a primary care summary of the BSCAI guideline. Prim Care Respir J. 2010;19(3):217–22. 

Anolik R, Mometasone Furoate Nasal Spray with Loratidine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(3):264–71.

Arshad SH. Natural history of allergic rhinitis. Global atlas of allergic rhinitis and chronic rhinosinusitis. 2014;64–5.

Azevedo P, Correia-de-Sousa J, Bousquet J, Bulgalho-Almeida A, Del Giacco SR, Demoly P et al. Control of allergic rhinitis and asthma test (CARAT): dissemination and applications in primary care. Prim Care Respir J. 2013;22:112–6.

Berger W, Hampel Jr F, Bernstein J, Shah S, Sacks H, Meltzer EO. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006;97:375–81.

Bousquet J, Van Cauwenberge P, Khaltaev N. ARIA workshop group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147–334.

Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy. 2003;58(8):691–706. 

Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62:367–72.

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008. Allergy. 2008;63(Suppl. 86):8–160.

Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A et al. MACVIA clinical decision algorithm in allergic rhinitis in adolescents and adults. J Allergy Clin Immunol. 2016;138(2):367–74.

Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG et al. Practical guide to skin prick test in allergy to aeroallergens. Allergy. 2012;67:18–24.

Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 2013;160:393–400.

Braunstahl GJ, Fokkens W. Nasal involvement in allergic asthma. Allergy. 2003;58(12):1235–43.

Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Walter G, Casale TB et al. Allergic rhinitis and its impact on asthma (ARIA) 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–76.

Canonica GW. Introduction to nasal and pulmonary allergy cascade. Allergy. 2002;57 (Suppl 75);8–12.

Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62:17–25.

Canonica GW, Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol. 2009;158(3):260–71. 

Church DS, Church MK, Scadding GK. Allergic rhinitis: impact, diagnosis, treatment and management. Pharmaceutical J. 2016:1–15.

Ciebiada M, Gorska Ciebiada M, Barylski M, Kmiecik T, Gorski P. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy. 2011;25(1):e1–6.

Ciprandi G, Incorvaia C, Scurati S, Puccinelli P, Soffia S, Frati F et al. Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey. Curr Med Res Opin. 2011;27:1005–11.

Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18(4):300–5.

Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol. 2000;84(5):533–8.

Demoly P, Allaery AA, Lecasble M, PRAGMA. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy. 2002;57:546–54.

Demoly P, Calderon MA, Casale T, Scadding G, Annesi-Maesano I, Braun JJ et al. Assessment of disease control in allergic rhinitis. Clin Transl Allergy. 2013;3:7.

Demoly P, Jankowski R, Chassany O, Bessah Y, Allaert FA. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy. 2011;41:860–8.

Diamant Z, van der Molen T. Treating asthma: is there a place for leukotriene receptor antagonists? Respir Med. 2005;99:655–62.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34:259–67.

The European Academy of Allergy and Clinical Immunology (EAACI). Allergy prevention recommendations. Available at http://www.eaaci.org/outreach/eaaci-2016-campaign/campaigns-english/allergy-prevention-recommendations/3894-allergies-and-asthma-reframing-the-conversation-from-disease-burden-to-prevention-and-health-promotion.html

Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18:693–704.

Gaugris S, Sazonov-Kocevar V, Thomas M. Burden of concomitant allergic rhinitis in adults with asthma. J Asthma. 2006;43(1):1-7.

Hampel FC, Ratner PH, van Bavel J, Amar NJ, Daftary P, Wheeler W et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105(2):168–73.

Han M, Shin S, Park H, Park KU, Park MH, Song EY. Comparison of three multiple allergen simultaneous tests: RIDA Allergy Screen, MAST Optigen, and Polycheck Allergy. Biomed Res Int. 2013; Article ID 340513.

Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R. A comparison of health care resource utilization and costs for patients with allergic rhinitis on single-product or free-combination therapy of intranasal steroids and intranasal antihistamines. J Manag Care Spec Pharm. 2016;22:1426–36.

Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36.

Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med. 2012;18:726–35.

Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy. 2000;55:7–16.

Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med. 2006;6(Suppl 1):S5.

Kaiser HB, Findlay SR, Geogitis JW, Grossman J, Ratner PH, Tinkelman DG et al. the anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated perennial allergic rhinitis. Allergy Asthma Proc. 1998;19(1):23–9.

Klimek L, Schendzielorz P. Early detection of allergic diseases in otorhinolaryngology. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008;7:Doc04.

Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104:301–4.

Linneberg A, Henrik Nielsen N, Frølund L, Madsen F, Dirksen A, Jørgensen T. The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study. Allergy. 2002;57(11):1048–52.

Lohia S, Schlosser J, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68(5):569–79.

Magnen A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy 2008;63:292–8.

Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA et al. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol. 2006;96(6):851–7.

Meltzer E, Ratner P, Bachert C, Carr W, Berger W, Canonica GW et al. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis. Int Arch Allergy Immunol. 2013;161:369–77.

Meltzer EO, NasalCrom Study Group. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study. Clin Ther. 2002;24(6):942–52.

Meltzer EO, Ratner PH, McGraw T. Phenylephrine hydrochloride modified-release tablets for nasal congestion: a randomised, placebo-controlled trial in allergic rhinitis patients. Ann Allergy Asthma Immunol. 2016;116(1):66–71.

Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2010;2:65–76.

Moscato G, Quirce S. Triggers of allergic rhinitis – work-related allergens. Global atlas of allergic rhinitis and chronic rhinosinusitis. 2014;121–3.

Mullol J. A survey of the burden of allergic rhinitis in Spain. J Investig Allergol Clin Immunol. 2009;19(1):27–34.

Navarro A, Valero A, Rosales MJ, Mullol J. Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis. J Investig Allergol Clin Immunol. 2011;21(5):363–9.

Norbäck D, Wang J. Environmental risk factors for allergic rhinitis – home environment. Global atlas of allergic rhinitis and chronic rhinosinusitis. 2014;106–7.

Peters-Golden M, Henderson WR Jr. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol. 2005;94:609–18.

Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases. Allergo J Int. 2014;23(8):282–319.

Price D, Scadding G, Ryan D Bachert C, Canonica GW, Mullol J et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy. 2015;5:39.

Price D, Kemp L, Sims E, von Ziegenweidt J, Navaratnam P, Lee AJ et al. Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma. Prim Care Respir J. 2010;19(3):266–73.

Rhinoconjunctivitis Quality of Life Questionnaire. Available at www.qoltech.co.uk/rqlq.html

Ryan D, van Weel C, Bousquet J, Toskala E, Ahlstedt S, Palkonen S et al. Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy. 2008;63(8):981–9.

Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007;62(Suppl 85):9–16.

Schmitt J, Stadler E, Küster D, Wüstenberg FG. Medical care and treatment of allergic rhinitis: a population-based cohort study based on routine healthcare utilization data. Allergy. 2016;71(6):850–8. 

Schroeder HW and Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125:S41–S52.

Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–57.

Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax. 1991;46:895–901.

Slavin RG. The upper and lower airways: the epidemiological and pathophysiological connection. Allergy Asthma Proc. 2008;29:553–56.

Smith P. Triggers of allergic rhinitis: inhalant allergens. Global atlas of allergic rhinitis and chronic rhinosinusitis. 2014;116–8.

Tong MCF, Lin JSC. Epidemiology of allergic rhinitis throughout the world. Global atlas of allergic rhinitis and chronic rhinosinusitis. 2014;62–3.

Tran NP, Vickery J, Blaiss MS. Management of rhinitis: Allergic and non-allergic. Allergy Asthma Immunol Res. 2011;3(3):148–56.

Valvorita E, Pawankar R. Survey of the impact of comorbid allergic rhinitis in patients with asthma. BMC Pulm Med. 200630;6(Suppl 1):S3.

Van Hoecke, Vastesaeger N, Dewulf L, Sys L, van Cauwenberge P. Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy. 2006;61:705–11.

Von Bubnoff D, Geiger E, Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol. 2001;108:329–39.

Wang Y, Chen H, Zhu R, Liu G, Huang N, Li W et al. Allergy. 2016;71:1612–9.

Winter WE, Hardt NS, Fuhrman S. Immunoglobulin E. Importance in parasitic infections and hypersensitivity responses. Arch Pathol Lab Med. 2000;124:1382–5.

Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM.Pediatrics. 1994;94:895–901.

Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol. 1999;103:54–9.

Zuberbier T, Lötvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review. Allergy 2014;69:1275–9.


 

Login/ Register Maximise Minimise